CRISPR-Based Delivery System Generates CAR T Cells In Vivo A two-vector delivery system generates tumor-targeting CAR T cells directly inside the body, achieving complete responses in mouse cancer models October 13, 2026 3 min The Medicine Maker Share Summary Takeaways Listen Insight Report Clinical Scorecard Quiz Poll